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Mutations in the apicobasal polarity gene CRB1 lead to diverse retinal diseases, such as
Leber congenital amaurosis, cone-rod dystrophy, retinitis pigmentosa (with and without
Coats-like vasculopathy), foveal retinoschisis, macular dystrophy, and pigmented paravenous chorioretinal atrophy. Limited correlation between disease phenotypes and CRB1
alleles, and evidence that patients sharing the same alleles often present with different disease features, suggest that genetic modifiers contribute to clinical variation. Similarly, the retinal phenotype of mice bearing the Crb1 retinal degeneration 8 (rd8) allele varies with genetic
background. Here, we initiated a sensitized chemical mutagenesis screen in B6.Cg-Crb1rd8/
Pjn, a strain with a mild clinical presentation, to identify genetic modifiers that cause a more
severe disease phenotype. Two models from this screen, Tvrm266 and Tvrm323, exhibited
increased retinal dysplasia. Genetic mapping with high-throughput exome and candidategene sequencing identified causative mutations in Arhgef12 and Prkci, respectively. Epistasis analysis of both strains indicated that the increased dysplastic phenotype required homozygosity of the Crb1rd8 allele. Retinal dysplastic lesions in Tvrm266 mice were smaller and
caused less photoreceptor degeneration than those in Tvrm323 mice, which developed an
early, large diffuse lesion phenotype. At one month of age, Müller glia and microglia mislocalization at dysplastic lesions in both modifier strains was similar to that in B6.Cg-Crb1rd8/Pjn
mice but photoreceptor cell mislocalization was more extensive. External limiting membrane
disruption was comparable in Tvrm266 and B6.Cg-Crb1rd8/Pjn mice but milder in Tvrm323
mice. Immunohistological analysis of mice at postnatal day 0 indicated a normal distribution
of mitotic cells in Tvrm266 and Tvrm323 mice, suggesting normal early development. Aberrant electroretinography responses were observed in both models but functional decline was
significant only in Tvrm323 mice. These results identify Arhgef12 and Prkci as modifier genes
that differentially shape Crb1-associated retinal disease, which may be relevant to understanding clinical variability and underlying disease mechanisms in humans.
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Arhgef12 and Prkci Modify Crb1rd8 Retinal Dysplasia in Mice

Author summary
Inherited eye diseases affect roughly 1:1,000 individuals worldwide. Although these diseases are often linked to variants of a single gene, it is increasingly recognized that a second variant in other genes may modify disease characteristics, including age of onset,
severity, and lesion appearance. Identifying such modifier genes in humans is difficult. In
this study, two modifiers of a gene associated with retinal damage leading to childhood
blindness in humans (CRB1) were identified in mice. Retinal damage caused by Crb1
mutation alone was less severe than in the presence of Arhgef12 or Prkci mutations. Furthermore, the modifier gene mutations caused retinal damage only in the presence of the
Crb1 mutation. Our results point to a role of mouse Crb1 and the modifying effects of
Arhgef12 and Prkci in a biological network that controls adhesive interactions between
cells. The variation in disease severity, lesion appearance, and visual responses in these
mice provide a dramatic example of modifier gene influence. This work may lead to an
improved understanding of the molecular basis of CRB1-associated retinal disease, with
possible relevance to diagnostic and therapeutic intervention in humans.

Introduction
Inherited retinal dystrophies associated with variants of the apicobasal polarity gene CRB1
exhibit a perplexing diversity of disease phenotypes (reviewed in [1–6]), including Leber congenital amaurosis (LCA8, MIM 613835), early-onset rod-cone dystrophy, juvenile- or adultonset retinitis pigmentosa (RP) with or without paraarteriolar preservation of the retinal pigment epithelium (RP12, MIM 600105), cone-rod dystrophy, RP with Coats-like exudative vasculopathy (retinal telangiectasia), hypermetropia, keratoconus, foveal retinoschisis and cystic
or retinoschisis-like maculopathy and macular dystrophy, and pigmented paravenous chorioretinal atrophy (PPCRA, MIM 172870). This variability in disease onset, progression, severity,
topography, and specific pathological features makes it difficult to advise patients about therapeutic options and key quality of life issues, and to identify suitable patients for participation
in prospective clinical trials [7]. Identifying the genetic and/or environmental factors responsible for clinical variability may therefore refine the prognosis of CRB1-associated diseases and
promote the development of therapeutic approaches.
Clinical variability may reflect the many biological processes in which CRB1 participates.
CRB1 encodes a mammalian member [8] of a family of transmembrane proteins related to
Drosophila Crumbs (Crb) [9], which are central to conserved CRB complexes that govern epithelial apicobasal polarity, cell-cell adhesion, apical segregation of proteins and lipids, cellular
size and shape determination, intercellular signaling, cell division, and tissue morphogenesis
[4,10–14]. In the Drosophila eye, Crb localizes to the stalk subdomain of the photoreceptor cell
apical membrane, where it mediates the assembly of adherens junctions and the apical segregation of cellular components [13,15–17]. Homozygous mutations of crb disrupt photoreceptor
cell morphogenesis and cause photoreceptor cell apoptosis and retinal degeneration [16,18].
In the mouse and human retina, CRB1 is most prominently localized to the subapical region
of the neural retina, specifically in photoreceptor inner segments above adherens and tight
junctions, and in Müller cell apical processes [8,16,19,20]. CRB1 disruption in mice perturbs
cell-cell adhesion at the external limiting membrane (ELM), as indicated by the focal loss of
adherens junctions [19,21]. CRB1 disruption is also associated with outer retinal folds and
pseudorosettes (retinal dysplasia) that correspond to light spots observed by fundus
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examination, and with photoreceptor degeneration in dysplastic regions [19–23]. Thus, CRB1
engages in multiple activities affecting cell and tissue integrity, raising the possibility that the
variability of CRB1/Crb1-associated retinal disease arises from the differential disruption of
these activities.
One hypothesis to explain disease variability is that CRB1 variants have allele-specific
effects. Nearly 300 pathogenic or likely pathogenic CRB1 alleles have been identified (https://
databases.lovd.nl/shared/genes/CRB1). Alleles may differ in their effect on protein levels, stability, or function, and variants affecting specific protein domains might be associated with
distinct CRB1-disease subtypes. Although most efforts to establish genotype-phenotype correlations have met with limited success to date [1–6], some recent clinical studies indicate potential correlations [7,24,25]. The correlation of disease-causing missense substitutions in the
extracellular domains of Drosophila Crb with variable cellular and retinal degeneration phenotypes [26] and the recent identification of a novel photoreceptor-specific isoform, CRB1-B, in
human and mouse retinas [21], may provide new perspectives for understanding these allelespecific effects.
It has also been suggested that variation in modifier genes may contribute to CRB1-associated disease variability. For example, mutations in genes encoding proteins that may directly
or indirectly interact with CRB1 could potentially mediate different pathogenic effects. In support of this hypothesis, distinct and variable disease phenotypes have been observed among
individuals with identical CRB1 alleles, suggesting the existence of genetic modifiers [2–
4,6,7,27–29]. Additionally, in about 30% of affected individuals only a single CRB1 variant
allele has been detected suggesting that other genetic variants, possibly including modifier loci,
may contribute to the disease [2]. However, apart from a report that an allele of the LCA and
RP gene, AIPL1, acted as a potential modifier of CRB1 retinal pathology [30], modifiers in the
human population have not been identified. Identification and validation of modifier genes is
challenging given the limited number of affected individuals for rare diseases, such as those
associated with CRB1 variants, the genetic heterogeneity of the human population, and the
possible effects of undefined environmental factors on disease phenotype.
The successful use of mouse models to identify genetic modifiers of human diseases [31,32]
extends to models of eye diseases [33], including CRB1-associated retinal dystrophy. Early evidence for genetic modifiers in a CRB1-disease model was obtained from studies of STOCK
Crb1rd8. This genetically mixed inbred strain exhibited extensive dysplasia observed as light
spots in the inferior nasal retina by indirect ophthalmoscopy and fundus imaging, which correspond to outer retinal pseudorosettes and folds [19,34]. In segregating crosses of STOCK
Crb1rd8 with the wild-type strains CAST/EiJ or C57BL/6J (B6), the dysplastic phenotype was
suppressed [19,34], indicating an effect of genetic background. Independent evidence for modifiers of the phenotype was obtained from breeding studies of strains harboring Crb1rd8 [35].
Variability of the dysplastic phenotype was also noted among mice derived from the C57BL/
6N (B6N) substrain, which is homozygous for the Crb1rd8 allele [36], and in strains from The
Jackson Laboratory (JAX) collection [37]. Cx3cr1, Mthfr, and Cygb were identified as modifiers
of Crb1rd8 retinal dysplasia [38–40], Jak3 as an enhancer of a Crb1rd8-dependent neovascular
phenotype [41], and Crb2 as a modifier of retinal dysplasia due to a Crb1 knock-out allele
[42,43]. Further, the choroidal neovascularization phenotype of an Nfe2l2 knock-out strain
[44] was more severe in the presence of homozygous Crb1rd8 alleles [45], indicating gene interaction. These studies reveal substantial variability in the retinal phenotype of Crb1 mutant
mice depending on genetic background and demonstrate that modifier genes can be identified.
However, the modifiers identified so far do not appear to participate in shared pathways, so
identification of additional modifier genes is needed to reveal the cellular and molecular networks that account for all of the observed CRB1-disease variability.
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Here, as part of the Translational Vision Research Models (TVRM) program [46–48], we
identified genetic modifiers that cause a more severe Crb1rd8 dysplastic retinal phenotype
using a sensitized N-ethyl-N-nitrosourea (ENU) mutagenesis screen of B6.Cg-Crb1rd8/Pjn
(hereafter B6 rd8) mice. These mice are congenic on the B6 background, homozygous for the
Crb1rd8 allele, and exhibit a near-normal fundus appearance [19]. Two mutant modifier lines,
Tvrm266 and Tvrm323, were found, respectively, to carry mutations in Arhgef12, which
encodes guanine nucleotide exchange factor 12, a modulator of Rho GTPase activity, and
Prkci, which encodes a protein homologous to Drosophila atypical protein kinase C, a component of the Baz-aPKC-Par-6 polarity complex that engages with Crb [10,49]. This work
extends the network of apicobasal polarity components that influence CRB1-associated retinal
disease and underscores its complexity and interconnectivity with multiple molecules and
pathways.

Results
Sensitized chemical mutagenesis screen of Crb1rd8 mice
Identification of variants contributing to the severe dysplastic phenotype in STOCK Crb1rd8
mice by classic genetical means of recombinant mapping proved to be inconclusive, likely due
to multigenic effects and gene interactions. Therefore, to identify genetic modifiers of Crb1rd8
dysplasia, two sensitized mutagenesis screens were considered initially: mutagenesis of
STOCK Crb1rd8 mice and screen for decreased severity of the fundus spotting phenotype, or
mutagenesis of B6 rd8, an incipient congenic strain with a mild phenotype [19], and screen for
increased severity of the phenotype. Mutagenesis of STOCK Crb1rd8 males failed to yield pups
in repeated attempts with varying concentrations and timing of ENU injections. Thus, mutagenized B6 rd8 males were bred according to an established strategy to detect both dominant
and recessive mutations [46], and the resulting G3 population screened for an increased spotting phenotype (Fig 1).

Identification of mutations
Two mutant lines, Tvrm266 and Tvrm323, exhibited a heritable, bilateral increase in fundus
spots in the inferior nasal retina compared to the parental B6 rd8 mice (Fig 2A) and were backcrossed for a minimum of five generations to unmutagenized B6 rd8 to remove unlinked
mutations prior to characterization. A high fraction of affected progeny during initial intercrosses to expand the colony suggested that the phenotype in both strains might be semi-dominant. The modifier loci were mapped by crossing these strains with B6N mice, which are
homozygous for the Crb1rd8 allele [36] and have diverged sufficiently from B6 to allow for
chromosomal mapping of the modifying loci without contributing to the observed disease
phenotypes. For Tvrm266 mice, high-throughput whole-exome sequencing of affected individuals was first performed to identify likely mutation candidates. For Tvrm323 mice, a genomewide recombinational mapping screen (S1 Fig and S1 Data) of 103 backcross progeny
((Tvrm323 × B6N) F1 × B6N) revealed that the interval yielding the highest frequency of
affected heterozygotes (72%) was a 15.3 Mbp region of Chromosome 3 (Chr 3; 03–021837059
to 03–037129353). Putative causative mutations were identified in Arhgef12, by Sanger
sequencing confirmation of candidate gene variants detected from the whole-exome sequences
of Tvrm266 mice, and in Prkci, by candidate gene sequencing within the confidence interval
identified by mapping Tvrm323 mice (Figs 2B and S2). T to A point mutations occurred in
both models resulting in an early stop signal at codon 24 of Arhgef12 (Fig 2B, asterisk) and substitution of asparagine for tyrosine at codon 136 of Prkci. Co-segregation of disease phenotype
with the mutations identified was statistically significant by endpoint genotyping analysis of 16

PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009798 June 8, 2022

4 / 33

PLOS GENETICS

Arhgef12 and Prkci Modify Crb1rd8 Retinal Dysplasia in Mice

Fig 1. Breeding strategy for chemical mutagenesis. B6 rd8 G0 males were treated with N-ethyl-N-nitrosourea (ENU). After about three months when G0
males regained fertility, they were mated to B6 rd8 females to produce G1 progeny. G1 males were mated to produce G2 progeny, of which four females were
backcrossed with the same G1 male to produce G3 progeny. G3 mice were screened by indirect ophthalmoscopy for evidence of increased retinal dysplasia. G3
founders were developed into TVRM models by testing for heritability and further backcrossing to remove unlinked mutagenized genes. The increased
spotting phenotype typical of retinal dysplasia is evident by comparing the fundus images of a B6 rd8 mouse (G0) and a G3 founder at 12 weeks of age.
Homozygosity of the Crb1rd8 allele is designated as rd8/rd8; mutant alleles of candidate modifier loci are designated as m/+ (heterozygous) or m/m
(homozygous).
https://doi.org/10.1371/journal.pgen.1009798.g001

progeny from a Tvrm266 mapping cross (Tvrm266 × B6N) F1 × B6N; p = 0.010, Fisher’s Exact
Test) and by sequencing 12 progeny from the Tvrm323 mapping cross (p = 5.4 × 10−5, Fisher’s
Exact Test), indicating that these mutations are causative (S2 Fig).
To assess the effect of the mutations on expression of the encoded proteins, western analysis
was performed on posterior eyecups. Analysis of ARHGEF12 in control B6 (Figs 2C and S3)
and B6 rd8 (S3 Fig) samples revealed a single band near the predicted molecular weight of
ARHGEF12 (171 kDa predicted for isoform X1, XP_017169054.1). Similar analysis of PRKCI
in B6 mice revealed a 66,000 Mr band consistent with the 65 kDa predicted for isoform X1
(XP_006535474). Quantitative western analysis (S4 Fig and S1 Data) indicated that the level of
ARHGEF12 in Tvrm266 eyes was no more than 0.037 of that in B6 eyecups (Student’s t-test,
p = 0.0015); this value is likely to be an overestimate arising from non-specific staining of other
eyecup proteins in the blot region analyzed. Little to no expression is expected due to the premature stop codon caused by the mutation. The expression of ARHGEF12 in both B6 and B6
rd8 mice (S3 Fig) suggested that the homozygous Crb1 mutation was not the cause of the dramatic decrease in ARHGEF12 expression in Tvrm266 mice. PRKCI levels in Tvrm323 mice
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Fig 2. Identification of mutations and protein expression in modifier strains. A. Fundus photodocumentation of B6 rd8 and
Tvrm266 mice at 10 weeks of age, and Tvrm323 mice at 3 months of age. Right (OD) and left (OS) eyes of a single mouse are
shown. The lower portion of each image corresponds to the inferior retina based on the position of the mouse head relative to
the camera during imaging. B. Sequence and amino acid translation of the mutant alleles. The DNA sequence corresponds to a
portion of the forward strand of each gene, numbered as in the mRNA. Mutations are indicated in bold above the sequence.
The predicted amino acid sequence is given beneath the DNA sequence using the single-letter code and the predicted
translational effect of the mutation is indicated in bold below. C. Enhanced chemiluminescence western analysis. Posterior
eyecup lysates from B6 control and modifier strains (n = 4) were electrophoresed and transferred to nitrocellulose. Tvrm266
blots were probed with ARHGEF12 antibody and Tvrm323 blots with PRKCI antibody. After imaging, blots were probed with
GAPDH antibody and reimaged to control for protein recovery and loading. Molecular weights of protein standards are
indicated in kDa.
https://doi.org/10.1371/journal.pgen.1009798.g002

were 0.57 of those in B6 mice but this effect was not statistically significant (Student’s t-test,
p = 0.052). Comparison of B6 rd8, Tvrm266, and Tvrm323 to B6 control eyecups by qRT-PCR
(S1 Data) indicated statistically significant differences in Arhgef12 mRNA levels among strains
(one-way ANOVA of ΔCt values, F[3,20] = 6.869, p = 0.0023). Dunnet’s post-hoc test revealed a
significant decrease in Arhgef12 mRNA levels (0.74 of B6, p = 0.0018) but not in other strains.
This decrease may reflect nonsense-mediated decay of a subset of Arhgef12 transcripts in
Tvrm266 mice. Parallel analysis of Prkci mRNA did not indicate significant post hoc differences
among the strains compared to B6 controls (S1 Data). Taken together, these results establish
novel alleles of two genes as candidate modifiers of the Crb1rd8 fundus phenotype. The full designation for these models is B6.Cg-Crb1rd8 Arhgef12Tvrm266/Pjn and B6.Cg-Crb1rd8
PrkciTvrm323/Pjn; for simplicity, we retain the original strain designations Tvrm266 and
Tvrm323, respectively, for the remainder of the paper, and unless otherwise indicated the
genotype is homozygous for both Crb1rd8 and the modifier.
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Epistasis of Crb1rd8 modifier genes
We postulated that the increased retinal spotting phenotypes of Tvrm266 and Tvrm323 may
be due to the new mutations acting alone or through an interaction with Crb1rd8. To distinguish these possibilities, we tested for epistasis, classically defined as the masking of a phenotype associated with a variant at one locus by a variant at a second [50]. To examine epistatic
interactions, each modifier strain was outcrossed to B6 mice, which are wild-type for Crb1,
and F1 progeny subsequently intercrossed to yield F2 mice. In the case of Tvrm266, F2 mice
progeny were genotyped and intercrossed to produce F3 mice of select genotypes for additional analysis. An increase in fundus spotting was observed in heterozygous or homozygous
Arhgef12Tvrm266 or PrkciTvrm323 mice in the presence of the homozygous, but not heterozygous
Crb1rd8 allele (Fig 3A). The fundus phenotype was more severe in the presence of two alleles
(homozygous) than with one allele (heterozygous) of either Arhgef12Tvrm266 or PrkciTvrm323.
These results were extended by indirect ophthalmoscopy to all nine genotypes expected from
the epistasis intercross (Fig 3B and 3C). Phenotypes of heterozygous Crb1rd8 mice were similar to those of B6 mice, which rarely exhibited spots (Fig 3A). Interaction modeling of indirect
ophthalmoscopy data (S1 Data) from epistasis crosses of both mutants indicated a significantly improved fit using a model that accounted for gene-gene interaction (Fig 3B and 3C)
compared to one that was purely additive (adjusted R2 value for interacting vs. additive models: Tvrm266 cross, 0.78 vs. 0.62; Tvrm323 cross, 0.89 vs. 0.69). An F-ratio test of the F-statistic
derived from the two statistical models was significant, indicating superior performance of
the interacting model for both mutants (F-statistic and p values: Tvrm266 cross, 26.1 and
p = 6.3 × 10−16; Tvrm323 cross, 97.9 and p = 5.4 × 10−46). Both analyses revealed a significant
effect of the heterozygous allele on the phenotype (Tvrm266 cross, p = 1.9 × 10−5; Tvrm323
cross, p = 1.6 × 10−8), which was smaller than that of the homozygous allele, confirming the
semi-dominant mode of inheritance. Taken together, these results reveal a semi-dominant
epistatic interaction between Arhgef12 or Prkci mutant alleles and the Crb1rd8 mutation leading to increased fundus spotting.

Pathological features of modifier strains
Having established that the Arhgef12 and Prkci alleles modify the Crb1rd8 phenotype, we
sought to gain insights into disease pathogenesis by studying the modified strains. Analysis
was performed on homozygous Tvrm266 and Tvrm323 mice, as the phenotype could be
observed at one month of age. To determine whether increased fundus spotting was correlated
with dysplastic lesions and other pathological changes, eyes collected from B6, B6 rd8,
Tvrm266, and Tvrm323 mice were examined histologically (Fig 4). We defined dysplastic
lesions as retinal folds or perturbations resulting in the displacement of photoreceptor nuclei
by more than three nuclear diameters from either boundary of the outer nuclear layer (ONL).
B6 rd8 retinas (Fig 4B) were morphologically similar to B6 retinas (Fig 4A) except for rare dysplastic lesions in the inferior retina (Fig 4B, asterisk; also compare the higher magnification
images in Fig 4E and 4F). By contrast, retinal morphology in the inferior retina was disrupted
more extensively in the modifier strains, as reported previously in STOCK Crb1rd8 mice
[19,23,34] and other Crb1 mutant models [20]. Lesions were also evident in the superior retina
of Tvrm266 and Tvrm323 mice near the optic nerve head. Dysplastic lesions were larger than
those in B6 rd8 mice (compare Fig 4G and 4H with Fig 4F) and differed between the two modifier strains. In Tvrm266 mice, the largest lesions (Fig 4C, asterisks; Fig 4G) extended toward
the inner nuclear layer (INL) and resembled the pseudorosettes described in STOCK Crb1rd8
mice and other models [19,20,23,34]. By contrast, Tvrm323 lesions were characterized by displacement of retinal cell layers toward the RPE (Fig 4D, asterisks; Fig 4H) and often contained
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Fig 3. A. Fundus photographs of B6, B6 rd8, and F3 progeny from the Tvrm266 epistasis cross at 10 weeks of age or F2 progeny from the Tvrm323 epistasis cross at 2.5–3.7
months of age. Genotypes are indicated by m/+ (heterozygous) or m/m (homozygous), where m is the mutant allele symbol and, for comparison with panels B and C, by
the values a, b at the upper right of each fundus image, which indicate the number of mutant alleles at the modifier and Crb1 loci, respectively (0, wild-type; 1,
heterozygous; 2, homozygous). At least 3 females and 3 males of each genotype were imaged bilaterally. B. 3D plot of the indirect ophthalmoscopy phenotypes of F2 and F3
progeny from the Tvrm266 epistasis cross (9–15 weeks of age) against the nine genotypes expected (n = 6–21 for each genotype). C. Corresponding plot of F2 phenotypes
from the Tvrm323 epistasis cross (2.5–3.7 months of age; n = 10–48 for each genotype). Indirect ophthalmoscopy annotations were converted to ordinal phenotype scores.
Scores for individual mice of each genotype examined are shown in blue, with fit statistical models represented by red circles. Genotypes values are indicated as in panel A.
https://doi.org/10.1371/journal.pgen.1009798.g003

tubular structures that reached and perturbed cells of this layer (Fig 4H, red arrowhead). These
structures may represent retinal neovessels, a frequently reported attribute of Crb1 mutant
mice and rats [35,41,51]. A novel feature discovered in modifier strains at one month of age
was the presence of apparent voids in the ONL near dysplastic lesions (Fig 4G and 4H, yellow
arrowheads). One sample with ONL voids was also observed among nine B6 rd8 mice examined (Fig 4I).
To assess the statistical significance of these findings, histological sections from each independent sample were reviewed for each pathological feature, scoring as affected any samples in
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Fig 4. Histological analysis at one month of age. A–D. Superior (S) and inferior (I) retinas cropped from digital images of B6, B6 rd8, Tvrm266 and Tvrm323 whole eye
sections stained with hematoxylin and eosin and imaged with a slide scanner. Dysplastic lesions, asterisks. Scale bar, 0.5 mm. Sites from A-D detailed in panels E–H,
respectively, are marked by arrowheads. E. Normal retinal layers in B6 mice. INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. F–H.
Dysplastic lesions in B6 rd8, Tvrm266, and Tvrm323 mice, respectively. Voids in panels G and H, yellow arrowheads. H. Lesion containing possible vascular structure, red
arrowhead. Scale bar, 50 μm; applies to E–H. I. Incidence of pathological features. Mice showing one or more of the identified features among 17–21 reviewed histological
sections were scored as affected. Asterisks denote statistical significance (Fisher’s exact test against B6 rd8 mice, p < 0.05). DL, dysplastic lesions; NV, neovessels. J.
Photoreceptor nuclei count within a 50 μm length of retina as a function of distance from the ONH. Values represent mean ± standard error of the mean (SEM); n = 5–8.
https://doi.org/10.1371/journal.pgen.1009798.g004
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which the feature occurred at least once. Compared to B6 rd8 mice, significant differences in
incidence were observed only for dysplastic lesions among B6 mice (Fisher’s exact test, Bonferroni post hoc correction, p = 0.0021), and for neovascular lesions among Tvrm323 mice (Fisher’s exact test, Bonferroni post hoc correction, p = 0.0026; Fig 4I, asterisks; S1 Data). To
determine whether these pathological changes were associated with photoreceptor degeneration, photoreceptor nuclei were counted in regions corresponding to a fixed length of the retinal perimeter, which were positioned at regular intervals over the entire retina. At one month
of age, no significant effect of strain on the number of photoreceptor nuclei was observed
among B6 mice or modifier strains compared to B6 rd8 mice (Fig 4J, repeated measures
mixed-effects model, F (3, 22) = 1.8, p = 0.18; S1 Data). These results show that retinal dysplasia and associated pathological changes occur at an early age prior to significant degeneration.
The topographical distribution of lesions in the inferior retina and the superior retina near the
ONH matched that of fundus spots, indicating that retinal dysplasia accounts for the increased
fundus spotting phenotype.

Age-dependent pathological changes in modifier strains
Most forms of CRB1 retinal disease are progressive in humans [1–6]. To examine whether progressive changes occurred with age in the modifier strains, histological analysis was repeated at
12 months of age (Fig 5). B6 rd8 retinal morphology was similar to that of B6 retinas in aged
mice (Fig 5A and 5E), except for rare dysplastic lesions as observed at one month of age (Fig
5B and 5F). By contrast, in addition to a continued presence of dysplastic lesions at 12 months
of age (Fig 5C and 5D, asterisks), retinas in both modifier strains exhibited areas of complete
photoreceptor loss, which were more extensive in Tvrm323 than in Tvrm266 mice (Fig 5C and
5D, solid lines). ONL voids were not observed, but neovascular lesions resulting in RPE perturbation were apparent in both modifier strains at this age (Fig 5G and 5H, red and white arrowheads). The incidence of neovascular lesions was statistically significant in both modifier
strains compared to B6 rd8 (Fig 5I and S1 Data). Analysis of photoreceptor nuclei counts indicated a statistically significant effect of strain (mixed-effects model, F (3, 36) = 21.42,
p < 0.0001). In post hoc analysis of data from both modifier strains, a statistically significant
decrease in nuclei counts was observed near the optic nerve head and extended more peripherally in the inferior than in the superior retina (Fig 5J and S1 Data). Importantly, degeneration
was limited to areas where dysplastic lesions were observed at one month of age (Fig 4C and
4D) and the peripheral retina was largely spared, as previously reported in STOCK Crb1rd8
mice [19]. No significant difference in nuclei counts was observed in post hoc analysis comparing B6 and B6 rd8 at 12 months of age, although an age-related decrease in counts throughout
the retina was evident in both strains (compare Figs 4J and 5J). Taken together with the histological findings at one month of age, these results establish that dysplastic lesions, neovascular
structures, and photoreceptor cell loss occur and progress to different extents among B6 rd8,
Tvrm266, and Tvrm323 mice, supporting the hypothesis that modifier genes contribute to
Crb1rd8 retinal disease variability.

Cellular disorganization at dysplastic lesions
Retinal dysplasia associated with mutant Crb1 alleles in mice and rats is characterized by mislocalized photoreceptor cells, shortened photoreceptor outer segments, dysmorphic Müller
cells, and the mobilization of immune cells, including microglia and possibly infiltrating macrophages, to the subretinal space [19,35,38,43,51]. Mislocalized rod photoreceptor cells were
readily identified in histological sections, as the nuclei of these cells in adult mice are compact
and stain intensely with hematoxylin (Fig 4). To assess rod outer segment integrity and to test
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Fig 5. Histological analysis at 12 months of age. A–D. Superior (S) and inferior (I) retinas cropped from representative digital images of B6, B6 rd8, Tvrm266 and
Tvrm323 whole eye sections stained with hematoxylin and eosin and imaged with a slide scanner. Dysplastic lesions, asterisks. Areas devoid of photoreceptor nuclei, solid
lines. Scale bar, 0.5 mm. Sites from A-D detailed in panels E–H, respectively, are marked by arrowheads. E. Normal retinal layers in B6 mice, labeled as in Fig 4. F.
Dysplastic lesion in B6 rd8. G, H. Photoreceptor loss at neovascular lesions (red arrowheads) in Tvrm266, and Tvrm323 mice, respectively. In G, red blood cells are
observed within a large vessel at the RPE. I. Incidence of pathological features among mice. Samples showing one or more of the identified features among 10–21 sections
were scored as affected. DL, dysplastic lesions; NV, neovessels. Asterisks denote statistical significance (Fisher’s exact test against B6 rd8 mice, p < 0.05). J. Photoreceptor
nuclei count within a 50 μm length of retina as a function of distance from the ONH. Values represent mean ± SEM; n = 6–8. Statistical significance colored according to
the strain compared to B6 rd8 in post hoc tests. p < 0.01, asterisk; p < 0.0001, hash symbol.
https://doi.org/10.1371/journal.pgen.1009798.g005
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if other retinal cells were abnormally distributed, immunofluorescence analysis of retinal sections was performed using antibody markers for photoreceptor outer segments, Müller glia,
and microglia (Fig 6). Rod and cone outer segments were correctly localized to the outer retina
in B6 mice (Fig 6A) and in intact retinal regions of B6 rd8, Tvrm266, and Tvrm323 mice (Fig
6B–6D). By contrast, outer segments were absent from the RPE interface at dysplastic lesions
in all three mutant strains. Small foci of rhodopsin (RHO) and M opsin (OPN1MW) staining
were observed throughout the dysplastic areas, consistent with mislocalization of photoreceptor cells.
In some instances, intact cone outer segments were observed in the interior of pseudorosettes (Fig 6C, arrowheads), suggesting infolding of the intact outer retina. In B6 mice, Müller
glia were observed with soma positioned at the center of the INL and retina-spanning processes extending to endfeet at the internal limiting membrane (ILM) and ELM (Fig 6E and 6I).
Similar morphology was observed in unaffected regions of B6 rd8, Tvrm266, and Tvrm323 retinas (Fig 6F–6H), but at dysplastic lesions, Müller cell bodies were occasionally displaced
toward the ONL (Fig 6F–6H and 6J–6L arrowheads). Müller cell displacement was observed in
2/4 lesions that were imaged in three B6 rd8 mice, 4/12 lesions in seven Tvrm266 mice, and
14/18 lesions in seven Tvrm323 mice. These results suggest that Müller cell displacement is a
common feature of dysplastic lesions, particularly those that are more severe as in Tvrm323
mice. Microglia were found in their normal locations on the outer surface of the INL in B6
mice (Fig 6M) and in unaffected regions of the three Crb1rd8 strains (Fig 6N–6P). By contrast,
at dysplastic lesions of these strains, microglial cells accumulated in the subretinal space or
appeared to be displaced toward this region (Fig 6N–6P). P2RY12 staining between the outer
plexiform layer and subretinal space indicated displacement of microglial cells and was
observed in 4/5 lesions imaged from five B6 rd8 mice, 7/9 lesions in six Tvrm266 mice, and 24/
24 lesions in eight Tvrm323 mice. This observation provides evidence for a strong correlation
between lesions and displaced microglia. As in other Crb1 mouse and rat models
[19,35,38,43,51], these results emphasize an enhanced focal pathology in Tvrm266 and
Tvrm323 mice that is limited to dysplastic lesions, in which photoreceptor cells are displaced
toward the INL from their normal locations and Müller cells and microglia are mobilized
toward the outer retina and RPE.

ELM fragmentation
Pan-retinal disruption of the ELM is a distinct feature of homozygous Crb1rd8 mice thought to
arise from a defect in the formation and maintenance of cell-cell adhesive interactions, which
depend on CRB1 [19]. This feature is observed in retinal sections of Crb1rd8 mutant mice
immunostained with antibodies against components of the cell adhesion machinery, such as
β-actin, cadherins, PALS1, or TJP1 [19,40], which reveal a fragmented appearance characterized by small gaps in the normally continuous ELM. It is unknown whether retinal dysplasia
requires ELM fragmentation or is instead the result of an independent pathological process.
To test whether fragmentation was affected by the modifier mutations, we stained retinal sections to detect TJP1. The ELM was continuous in the inferior (Fig 7A) and superior retina (Fig
7E) of B6 mice but exhibited gaps in the corresponding regions of B6 rd8 (Fig 7, 7B and 7F)
and Tvrm266 mice (Fig 7, 7C and 7G). Strikingly, however, ELM fragmentation was rare in
Tvrm323 retinas (Fig 7, 7D and 7H), despite an increase in the number and size of dysplastic
lesions. The decrease in the number of gaps relative to B6 rd8 was particularly noticeable in the
superior retina of Tvrm323 mice, which at one month of age had no dysplastic lesions (compare Fig 7H and 7F). Note that the ELM is distorted at dysplastic lesions (for example, Fig 7B)
and therefore fragmentation cannot be evaluated at these sites. Gap counts normalized to ELM
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Fig 6. Ectopic retinal cells in dysplastic lesions at one month of age. Retinal sections of 7–9 B6 (A, E, I, M), B6 rd8 (B, F, J, N), Tvrm266 (C, G, K, O), and Tvrm323 (D,
H, L, P) mice were examined for each panel of markers studied. A–D. Staining with rhodopsin (RHO, red) and M cone opsin (OPN1MW, green) antibodies indicated a
normal location of rod and cone outer segments in B6 mice (A) but an ectopic location at dysplastic lesions of Crb1rd8 mutants (B–D; white and yellow arrowheads,
respectively). E–H. Glutamine synthetase (GLUL, green) antibodies revealed Müller cell soma at the center of the INL in B6 mice (E, detailed in I) but displaced toward the
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ONL at lesions of Crb1rd8 mutants (F–H, white arrowheads, detailed in J–L). M–P. Purinergic receptor P2RY12 antibodies (green) revealed microglia at their normal
location in the OPL of B6 mice but mobilized to the ONL and subretinal space among dysplastic lesions of Crb1rd8 mutants (arrowheads). Nuclei were detected with DAPI
(blue). Scale bars: H, 50 μm, applies to A–H and M–P; L, 25 μm, applies to I–L.
https://doi.org/10.1371/journal.pgen.1009798.g006

length in areas unaffected by dysplasia were determined as a measure of fragmentation (Fig 7I
and S1 Data). A statistically significant difference in this measure was observed in one or more
strains compared to B6 rd8 (one-way ANOVA, F (3, 12) = 38.90, p <0.0001; S1 Data). In post
hoc analysis corrected for multiple comparisons by Dunnet’s test, statistically significant differences in fragmentation were observed in B6 and Tvrm323 (p < 0.0001), but not Tvrm266
(p = 0.091) mice, compared to B6 rd8 mice (Fig 7I, asterisks; S1 Data). These results provide
further evidence that genetic modifiers affect Crb1rd8 phenotypes differentially and raise the
possibility that dysplasia and ELM fragmentation may be independent pathological changes
arising from the Crb1rd8 mutation.
We also tested whether the homozygous Arhgef12Tvrm266 mutation might result in an ELM
phenotype in the absence of the homozygous Crb1rd8 allele. Compared to Tvrm266 mice, the
gap number per mm of ELM in mice bearing the homozygous Arhgef12Tvrm266 mutation and a
heterozygous Crb1rd8 allele was significantly reduced to a value near zero (S5 Fig). This result
indicates that the ELM fragmentation phenotype of Tvrm266 mice requires homozygous
Crb1rd8 and suggests that the Arhgef12 mutation does not result in gross changes to the ELM.

Effect of modifiers on neonatal retinal progenitor cell development
Studies of severely dysplastic Crb1 mutant mice that also carry conditional mutations in Crb2
targeted to photoreceptor cells, retinal progenitor cells, or Müller glia have revealed defects in
early retinal development [43]. In these strains, mitotic progenitor cells of the retinal neuroblastic layer (NBL), which at P1 are normally localized within a narrow band near the RPE, are
distributed ectopically throughout the NBL and even reach the ganglion cell layer [43]. To test
for ectopic localization of mitotic progenitor cells in our Crb1rd8 modifier strains, we examined
retinal sections at P0 from B6, B6 rd8, Tvrm266, and Tvrm323 mice stained with antibodies
against phosphohistone H3 (PHH3) (Fig 8), which identifies cells at mitotic prophase and
metaphase. Mitotic progenitor cells were similarly positioned at the NBL apical surface of all

Fig 7. ELM fragmentation in modifier strains. Retinal sections from mice at one month of age were stained with antibodies against TJP1 (red) to detect the ELM and
DAPI (blue) to detect nuclei. A–D. Inferior retina. E–H. Superior retina. A, E, B6; B, F, B6 rd8; C, G, Tvrm266; D, H, Tvrm323. Gaps are indicated by yellow arrowheads.
Images are representative of n = 8 samples from each strain. H. Scale bar, 50 μm, applies to all image panels. I. Count of gaps over the full length of ELM except at
dysplastic lesions, normalized to ELM length (n = 3–4). Bars indicate mean ± SEM. Asterisks, p < 0.0001, post hoc analysis.
https://doi.org/10.1371/journal.pgen.1009798.g007
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Fig 8. Distribution of mitotic progenitor cells at P0. A–D. Representative ocular sections of B6 (n = 5), B6 rd8 (n = 6), Tvrm266 (n = 5), or Tvrm323 (n = 7) mice,
respectively, were probed with antibodies against phosphohistone H3 (PHH3, red) to detect mitotic cells and DAPI (blue) to detect nuclei. A similar distribution of
PHH3-positive staining within the outer NBL (A, arrow) was observed in all strains. E–H. Detail of P0 retinas stained as in A–D and with antibody against TJP1 (red).
The order of samples is the same as in A–D. Placement of progenitor cells undergoing mitosis close to the apical boundary of the NBL, delineated by TJP1, was observed
in all strains. NBL, neuroblastic layer. Scale bars: D, 0.25 mm, applies to A–D; H, 50 μm, applies to E–H. I. Quantitation of PHH3 fluorescence in a 20 μm-wide band at
the apical NBL relative to the total NBL. J. Quantitation of gaps per mm of the prospective ELM. Bars in I and J indicate mean ± SEM.
https://doi.org/10.1371/journal.pgen.1009798.g008

strains (Fig 8A–8H). Analysis of the PHH3 fluorescence distribution of P0 mice (Fig 8I)
revealed no significant difference due to strain (one-way ANOVA, F (3, 19) = 1.48, p = 0.25,
n = 3, 6, 5, and 7 for B6, B6 rd8, Tvrm266, and Tvrm323, respectively). Similarly, TJP1 staining,
which at P0 detects the prospective ELM, revealed few gaps (Fig 8E–8H). There were no statistically significant differences in the number of gaps per mm of ELM (Fig 8I) due to strain
(one-way ANOVA, F (3, 12) = 0.92, p = 0.47, n = 3, 4, 4, and 5 for B6, B6 rd8, Tvrm266, and
Tvrm323, respectively). Thus, our analysis does not reject the hypotheses that mitotic progenitor cell localization and prospective ELM integrity at P0 are unaffected by the homozygous
Crb1rd8 mutation alone or in combination with the Arhgef12 or Prkci modifier mutations.

Loss of visual function in modifier strains
Loss of vision in CRB1-associated retinal disease occurs congenitally in LCA patients or progresses rapidly during early life in RP and cone-rod dystrophy patients. In comparison, mouse
strains carrying a single homozygous Crb1 mutation exhibit little to no progressive reduction
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in visual function as measured by electroretinography (ERG) [20,22,23], limiting their utility
as models of CRB1-associated vision loss. Functional loss in mouse models is accelerated in
strains combining homozygous Crb1 mutations with modifier mutations, such as those in
Crb2 [42,43,52]. To assess whether a decline in visual function was accelerated in Crb1rd8 modifier strains, B6, B6 rd8, Tvrm266, and Tvrm323 mice were examined by ERG. As no significant
loss of photoreceptors was noted histologically at one month of age, scotopic and photopic
ERG response amplitudes as a function of flash intensity were measured at four, eight, and 12
months of age (Fig 9A). Scotopic a- and b-wave amplitudes provide a measure of rod photoreceptor and secondary neuron function while the photopic b-wave amplitude measures secondary neuron responses to cone stimulation. Responses at each age were compared statistically to
those of B6 rd8 by mixed-effects analysis, a repeated-measures approach that allows datasets
with occasionally missing values. By this analysis (S1 Data), statistically significant differences
in mean scotopic a-wave amplitude were detected in one or more strains compared to B6 rd8
mice (4 months, p = 0.0306; 8 months, p = 0.0022; 12 months; p = 0.0004); in mean scotopic bwave amplitude (8 months, p = 0.0009; 12 months; p = 0.0002); and in mean photopic b-wave
amplitude (8 months; p = 0.0034; 12 months; p = 0.0021). Post hoc analysis with Dunnet’s correction for multiple comparisons revealed a statistically significant decrease in Tvrm266 awaves amplitude at a single flash intensity (4 months; -1.8 log cd s/m2; p = 0.046) and in
Tvrm323 at multiple intensities (12 months; -1.4, -1.0, and-0.6 log cd s/m2; p = 0.017, 0.032,
and 0.35, respectively). Parallel analysis indicated an unusual and statistically significant
increase in mean Tvrm266 b-wave amplitude (8 months; -1.4, -1.0, and-0.6 log cd s/m2;
p = 0.031, 0.013, and 0.0070, respectively) as well as statistically significant decreases in mean
Tvrm323 b-wave amplitude (8 months; 1.8 log cd s/m2; p = 0.049; 12 months; -2.6, -2.2, -1.8,
-1.0, and-0.6 log cd s/m2; p = .0098, 0.013, 0.029, 0.013, and 0.0098, respectively). No other
comparisons, including those of B6 to B6 rd8 were found to be statistically significant (S1
Data). These results indicate a transiently increased ERG response in Tvrm266 mice at eight
months of age, which is unexpected in light of the decreased number of photoreceptor cells
predicted from histological analysis. They also indicate a loss of photoreceptor function in
Tvrm323 mice as indicated by the statistically significant decrease in scotopic a- and b-wave
amplitudes at 12 months of age.
As an alternative measure of progressive functional changes within each strain, we reanalyzed ERG response amplitudes obtained at the highest scotopic and photopic flash intensities
as a function of age (Fig 9B and S1 Data). In this analysis, amplitude values at each age were
normalized and compared to the mean value at four months of age. Statistically significant differences in response amplitudes at one or more ages were detected in all strains except B6 (S1
Data; two-way ANOVA; scotopic a- and b-wave, photopic c-wave; p < 0.0001). Post hoc analysis with Dunnet’s correction for multiple comparisons revealed a statistically significant
decrease in mean B6 rd8 response amplitudes (12 months; scotopic a-wave; p = 0.0082; scotopic b-wave, p = 0.0020; photopic b-wave, p = 0.013); a statistically significant increase in
Tvrm266 amplitudes (8 months; scotopic a-wave; p = 0.0001; scotopic b-wave, p < 0.0001) and
a statistically significant decrease in Tvrm323 amplitudes (8 months; scotopic a-wave;
p = 0.0007; scotopic b-wave, p < 0.0001; photopic b-wave, p = 0.017; 12 months; scotopic awave; p < 0.0001; scotopic b-wave, p < 0.0001; photopic b-wave, p < 0.0001). Comparison of
the mean values indicated a progressive and statistically significant decrease in ERG response
amplitudes in B6 rd8 mice of 30–40% from four to 12 months of age, which was exacerbated in
Tvrm323 mice to 44–63% over the same period, consistent with degeneration of rod and cone
photoreceptor cells (Fig 9B). Tvrm266 mice showed increased scotopic responses of 45–51% at
eight months of age, a difference which was not sustained at 12 months of age. In summary,
the ERG data provide evidence for functional changes in the modifier strains, which differ
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Fig 9. ERG analysis of B6, B6 rd8, Tvrm266, and Tvrm323 mice at four, eight, and 12 months of age. A. Scotopic and photopic response amplitudes as a
function of flash luminance. Asterisks show statistical significance in a comparison to B6 rd8 and are colored as in the legend to indicate the strain compared.
�
p < 0.05; �� p < 0.01. Values indicate mean ± SEM; n = 6–26. B. Response amplitudes at the highest flash luminance as a function of age, normalized to the
mean amplitude at four months of age. Legend is the same as in panel A. Asterisks indicate statistical significance compared to the value at four months of
age and are colored as in the legend in panel A. � p < 0.05, �� p < 0.01; ��� p < 0.001; ���� p < 0.0001.
https://doi.org/10.1371/journal.pgen.1009798.g009
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from each other and from B6 rd8 mice, supporting the hypothesis that Crb1rd8 modifiers differentially affect retinal function.

Discussion
Modifier genes can alter the onset, progression, severity, and specific characteristics of monogenic ocular diseases, presenting challenges for patient diagnosis, prognosis, and treatment
[7,33]. Our finding that mutations in murine Arhgef12 and Prkci modulate Crb1rd8 retinal phenotypes to differing extents and with different lesion characteristics further supports the
hypothesis that modifier gene variants contribute to clinical variability in CRB1-associated retinal dystrophy. Our results provide insight as to the pathogenic process and expand the growing network of Crb1rd8 modifier genes that may ultimately lead to a greater understanding of
underlying disease mechanisms that lead to the vast array of CRB1 associated disease phenotypes. The models reported here present with new retinal phenotypes, which more closely
recapitulate the human disease and may be useful for pre-clinical studies.
Defects in a number of apicobasal polarity proteins have been observed to cause retinal dysplasia. Three conserved protein complexes first identified in invertebrates are thought to determine apicobasal polarity in epithelial cells and other polarized cell types: the Drosophila CrbSdt-Patj complex [mouse orthologs CRB(1–3)-MPP5- PATJ], the Drosophila Baz-aPKC-Par-6
complex [PARD3(or PARD3B)-PRKC(I or Z)-PARD6(A, B, or G)], and the Drosophila ScribDlg1-L(2)gl complex [SCRIB-DLG(1–5)-LLGL(1 or 2)] [53–55]. These complexes direct the
formation of cell-cell adhesion complexes, including tight and adherens junctions that further
establish the apical, lateral, and basal domains of epithelial cells [56]. Members of the Rho family of small signaling GTPases are also important for the establishment and maintenance of
epithelial apicobasal polarity [56–59]. For example, Drosophila Cdc42 is responsible for the
membrane localization and apical accumulation of Baz, aPKC, Par-6 and Crb, and may mediate exchange of the aPKC-Par-6 subcomplex from Baz to Crb [49]. By contrast, Drosophila
Rho function is required for cytoskeletal remodeling that stabilizes cadherin-based cell-cell
adhesion and reinforces apicobasal polarity [60]. In vertebrate models, mutation or loss of zebrafish (Danio rerio) orthologs of apicobasal polarity proteins EPB41L5 (zebrafish moe) [61,62],
MPP5 (nok) [63], and CRB2 (ome) [64] cause retinal developmental and lamination abnormalities similar to Crb1-associated retinal dysplasia. Deficits in mouse CRB1 [19,20,23], CRB2
[65–67], CRB1 and CRB2 combined [42,52,67], MPP5 [68], and PRKCI [69] have similar
effects, supporting the hypothesis that defects in apicobasal polarity cause retinal dysplasia.
Our results also support this hypothesis. Retinal dysplasia is more severe in Tvrm323 mice,
which express variants of two apiocobasal polarity proteins, PRKCI and CRB1, when compared to B6 rd8 mice, in which only CRB1 is disrupted. Our epistasis analysis demonstrated a
genetic interaction between Prkci and Crb1 in retinal dysplasia, consistent with known interactions between PRKCI and CRB1 in apicobasal polarity [53–55]. PrkciTvrm323 is a novel missense allele, so it is informative to consider its effect on PRKCI function. As ablation of Prkci
in mice results in lethality by embryonic day 9 [70], the normal viability of homozygous
PrkciTvrm323 mice suggests that the mutant allele does not compromise PRKCI functions
required for growth and survival. Likewise, in the absence of the homozygous Crb1rd8 mutation, mice carrying the PrkciTvrm323 allele do not appear to cause retinal dysplasia, unlike conditional mutants that ablate the gene in differentiating, post-mitotic photoreceptor cells,
resulting in severe retinal dysplasia [69]. Moreover, accumulation of PRKCI in Tvrm323 and
B6 eyecups does not differ significantly, indicating that the mutation has little effect on protein
synthesis or turnover. The PrkciTvrm323 mutation results in substitution of asparagine for tyrosine at amino acid position 136 of PRKCI, which has been identified as a phosphorylated
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residue in independent phosphoproteomic studies (PhosphoSite, accessed March 9, 2022).
This position lies between a pseudosubtrate sequence (PSR, residues 124–134) and adjacent
conserved domain (C1, 141–193) (NCBI Gene, accessed March 9, 2022). Studies of the closely
related atypical protein kinase PRKCZ indicate that the tandem PSR and C1 domains bind
and allosterically regulate the kinase catalytic domain [71], and studies of both PRKCI and
PRKCZ indicate that the C1 domain also controls the binding and response of these enzymes
to signaling lipids, such as phosphatidylserine, phosphatidic acid, and phosphatidylinositol
monophosphates [72]. Together with our observations, these findings raise the possibility that
the Tvrm323 phenotype results from disruption of a signaling pathway evoked in response to
the Crb1rd8 mutation, in which phosphorylation of PRKCI residue 136 alters the enzymatic
autoregulation of PRKCI and/or its binding to signaling lipids. PRKCI kinase function is critical for apicobasal polarity and adherens junction formation [73], and alteration of kinase autoregulation may disrupt these processes. Alteration of lipid binding may also affect PRKCI
membrane localization and, by analogy with the apicobasal polarity processes in Drosophila
discussed above, may disrupt PRKCI association with a PARD6A, B, or G isoform and/or
binding of the resulting complex to CRB1.
Our results also point to disruption of a Rho GTPase-mediated apicobasal polarity process
in Crb1rd8 retinal dysplasia. Epistatic analysis revealed a genetic interaction between Arhgef12
and Crb1 alleles that led to enhanced retinal dysplasia, suggesting that both genes participate
in the same pathogenic pathway. ARHGEF12 protein was undetectable in Tvrm266 eyecups,
suggesting that Arhgef12Tvrm266 is a null allele. ARHGEF12 (also known as LARG) belongs to
the Dbl protein family of guanine nucleotide exchange factors, which are defined by a diffuse
B-cell lymphoma (Dbl)-homology domain that activates Rho GTPases by exchanging bound
GDP for GTP [74–76]. ARHGEF12 preferentially activates RHOA and to a lesser extent
RHOB and RHOC [76–79], potentially affecting their function in apicobasal polarity [56–59].
Several reports suggest ARHGEF12 interacts with Rho GTPases to regulate actin remodeling
at sites of cell-cell adhesion. ARHGEF12 is a component of the E-cadherin adhesome defined
by proximity proteomics in human gastric adenocarcinoma cells, an epithelial cell model [80].
ARHGEF12 colocalizes and physically interacts with WTIP, an adaptor protein required for
stabilizing cell-cell adhesions as they form in mouse renal podocytes [81]. In cultured human
cells, ARHGEF12 mediates RHOA-CDC42 cross-talk in a complex with two other Dbl proteins, ARHGEF11 and PLEKHG4B [79], which directs actin remodeling at cell-cell junctions
as they mature [82]. Interestingly, ARHGEF12 guanine nucleotide exchange activity requires
interaction with the activated α subunits of heterotrimeric G proteins, Gα12, Gα13, and Gαq
[77,78,83–85] and are therefore regulated by the stimulation of G protein coupled receptors
(GPCRs) that activate these subunits [85–87]. Together with our results, these observations
lead us to propose that a GPCR agonist generated in response to the homozygous Crb1rd8
defect stimulates ARHGEF12 activation of a Rho GTPase, which may promote actin remodeling at cell-cell junctions to reinforce cell apicobasal polarity. Accordingly, the loss of ARHGEF12 in Tvrm266 mice would abolish this response and exacerbate retinal dysplasia. Thus,
our findings raise the possibility that the increased dysplasia of Tvrm266 mice is due to combined defects in two proteins that influence apicobasal polarity, CRB1 and ARHGEF12.
An open question is how the genetic interactions of Arhgef12 and Prkci with Crb1 are mediated at the cellular level. While it is conceivable that dysplasia is due to dysfunction or loss of
the encoded proteins in a single cell type, available evidence suggests that the proteins are
expressed in multiple cell types, which furthermore may vary developmentally. Retinal CRB1
has been detected in both Müller and photoreceptor cells [16,19], only Müller cells [88], or separately in Müller and photoreceptor cells depending on whether CRB1-A, CRB1-B, or both
isoforms were targeted by the antibody used [21]. Crb1 transcripts are detected in retinal
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progenitor cells is expressed starting at embryonic day 11.5 [89]. Crb1 is also expressed in vascular endothelial cells of the mouse retina and upregulated under conditions associated with
increased endothelial cell polarization [90]. Mouse PRKCI is widely distributed among retinal
progenitor cells at the apical surface of the NBL at P0, but mainly in the inner nuclear and ganglion cell layers at P9 [69]. Like Crb1, Prkci transcripts are detected in retinal endothelial cells
and increase in abundance with cell polarization [90]. There is genetic evidence that PRKCI
functions in these cells [91]. Retinal endothelial cells also express Arhgef12 transcripts during
postnatal angiogenesis in mice at P8 [92]. From single-cell RNA sequencing online resources
(The Broad Institute Single Cell Portal, https://singlecell.broadinstitute.org/single_cell,
accessed March 12, 2022), Arhgef12 transcripts were observed in retinal progenitor cells at
embryonic day 13.5 [93] and in amacrine, horizontal, and ganglion cells, astrocytes, fibroblasts, pericytes, and vascular endothelium at P14 [94], while Prkci transcripts were detected in
horizontal cells [94]. Although these studies support the hypothesis that apicobasal polarity
defects in retinal progenitor cells cause retinal dysplasia, the observation that Arhgef12, Prkci,
and Crb1 genes are expressed in retinal endothelial cells raises the intriguing possibility that
vascular cell polarity defects may also contribute to the disease. Further studies to resolve the
pathogenic roles of specific retinal cell types expressing these proteins are needed to advance
our understanding of disease mechanisms.
The phenotypes observed in Tvrm266 and Tvrm323 mice provide important insights
regarding the pathogenic process(es) leading to retinal dysplasia. First, photoreceptor cell
nuclei and outer segments are mislocalized only at dysplastic lesions. Second, in dysplastic
lesions of both models and B6 rd8 mice, Müller cell soma are displaced from their normal location in the center of the inner nuclear layer toward the RPE. Similar displacement has been
observed in other murine retinal injury models [95,96]. Third, compared to B6 control animals, microglia at lesions are mobilized toward the subretinal space in both modifier strains
and in B6 rd8 mice. Similar immune cell mobilization observed in other homozygous Crb1rd8
strains [35,38,43] may indicate a contribution of these cells to lesion formation, although direct
tests of this hypothesis have not been reported. Fourth, ELM fragmentation, which arises from
a focal loss of cell-cell adhesion among Müller and photoreceptor cells, is reduced in Tvrm323
mice compared to Tvrm266 and B6 rd8 mice, despite increased dysplasia. This result raises the
possibility that ELM fragmentation and retinal dysplasia are independent phenotypes associated with Crb1 mutation, in agreement with previous observations that dysplasia can be suppressed without affecting fragmentation [19] and that certain Crb1 mutants exhibit dysplasia
while retaining an ELM structure similar to that of wild-type controls [20]. Fifth, cyst-like
structures within the outer nuclear layer of both models accumulate in the region of the retina
where dysplastic lesions occur. These structures may be related to foveolar retinoschisis [97] or
macular edema [98], often detected in CRB1 RP patients [25,99]. The cause of these cyst-like
structures is unknown but, based on the observation of vascular leaks upon Müller cell ablation
[100], they may ultimately arise from defects in junctions between Müller cells and retinal vascular beds. Finally, in Tvrm266 and Tvrm323 mice at both one month and one year of age, vascular structures are observed in dysplastic regions, some of which include displaced RPE cells.
Vascular structures related to retinal angiomatous proliferation are observed in other Crb1
mutant modifier strains [38,39,41,43], and macular telangiectasia-like structures have been
reported in a rat Crb1 mutant [51]. Taken together, these results suggest a pathogenic process
in which disruption of apicobasal polarity complexes results in abnormal activation of Müller,
immune, and vascular cells, leading to edema, neovascular changes, and focal tissue remodeling observed as dysplastic lesions. Further studies of Tvrm266 and Tvrm323 mice may help
elucidate the molecular mechanisms that underlie this process.
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Our results add to a growing list of reported Crb1rd8 modifier genes, which include Cx3cr1,
Mthfr, Crb2, Cygb, Jak3, and Nfe2l2 [35,39–43,45]. Analysis of modifier genes in mouse models
of other diseases have been useful for assembling genetic networks that provide important clues
to pathogenesis and offer new avenues for therapeutic intervention [31,32]. As discussed above,
Crb1, Crb2, Arhgef12, and Prkci may be placed in a network of apicobasal polarity genes. However, it is not obvious how the remaining modifier genes identified to date fit into this network.
Cx3cr1 encodes an immune-cell receptor for fractalkine, a signaling molecule expressed predominantly in the central nervous system and upregulated in injured neurons [101]. Mthfr
encodes 5,10-methylenetetrahydrofolate reductase, a folate metabolic enzyme that influences
serum homocysteine levels and is implicated in diverse conditions, including neurodegenerative
disease [102]. Cygb encodes cytoglobin B, an oxygen-binding protein expressed in vascular pericytes that may protect against cellular oxidative damage [103]. Jak3 encodes a signaling kinase
that regulates myeloid and lymphoid cell development and activation [104,105], and Nfe2l2
encodes a transcriptional factor in many cell types that regulates oxidative stress genes [106].
Although all these genes can conceivably be associated with the phenotypes we observe, identifying additional genes that fill in missing connections will be necessary to construct a comprehensive network to explain retinal dysplasia. Our study has highlighted the utility of a sensitized
mutagenesis screen to identify Crb1rd8 modifier genes, which will continue to extend the network. These efforts may be amplified by the characterization of retinal dysplasia among B6Nderived strains generated by the Knockout Mouse Phenotyping Program and International
Mouse Phenotyping Consortium, where every knock-out line also bears the Crb1rd8 mutation
[107, 108]. The potential of this second approach has been demonstrated [40].
The identification of Arhgef12 and Prkci as Crb1 modifier genes in mice may have relevance to
diagnosing and developing treatments for human CRB1-associated retinal disease. Some patients
possessing a single identified CRB1 variant allele may be affected due to modifier gene variants
[2]. For example, it has been suggested that CRB2 variants may modify CRB1 alleles in humans
[42,43]. The increased retinal dysplastic phenotype of conditional Crb2 mutant mice carrying heterozygous Crb1 knockout alleles [42,43] suggests this effect could occur among patients bearing a
single mutant CRB1 allele. Thus, identifying Crb1 modifiers in mice, such as Arhgef12 and Prkci,
may provide gene candidates for diagnostic screening of patients who retain only a single mutant
CRB1 allele. In addition, the altered disease characteristics caused by Crb1 modifier genes, including but not limited to Arhgef12 and Prkci, may aid in disease prognosis. If disruptive variants of
mouse Crb1 modifier genes are found in CRB1 patients, a better prediction of disease onset, progression, severity and specific pathological features might be possible based on the corresponding
murine phenotypes. Further, the mouse models described here exhibit new features aligned with
human CRB1 pathology, which may aid in developing therapies. The cyst-like lesions in both
Tvrm266 and Tvrm323 mice may be useful for understanding the origin of and testing treatments
for macular and foveal retinoschisis associated with CRB1 variants [25,97–99]. The progressive
decline in rod and cone cell ERG responses in Tvrm323 mice is faster than in mice carrying a single homozygous Crb1 mutation, including STOCK Crb1rd8 mice, and may be useful for understanding and treating functional decline in CRB1 patients. Translational studies using these
Crb1rd8 modifier mouse models, which are readily available to researchers, may yield insights that
improve the care of patients affected by CRB1-dependent retinal dystrophy.

Methods and materials
Ethics statement
All procedures utilizing live mice were approved by the JAX Institutional Animal Care and
Use Committee (protocol ACUC 99089).
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Colony management and ENU mutagenesis
STOCK Crb1rd8 mice were backcrossed to C57BL/6J (JAX stock number 000664) mice for
seven generations to produce an incipient congenic strain, B6.Cg-Crb1rd8/Pjn (N7), which was
bred to homozygosity. Males from this incipient congenic colony were administered weekly
intraperitoneal injections of ENU (Millipore Sigma, Burlington, MA, USA; N3385) for three
consecutive weeks at a concentration of 80 mg/kg per treatment [109,110]. Following return to
fertility, the mutagenized G0 males were backcrossed to B6.Cg-Crb1rd8/Pjn females, producing
G1 mice which were subsequently outcrossed to unmutagenized B6.Cg-Crb1rd8/Pjn (N7) and
resulting female G2 mice were backcrossed to G1 sires to produce G3 mice [46].
G3 mice were screened at 12 weeks of age using indirect ophthalmoscopy. Heritability of
novel ocular phenotypes was established by outcrossing to B6.Cg-Crb1rd8/Pjn (N7) mice, producing F1 progeny to test for dominance. If no phenotype was observed, F1 mice were then
intercrossed, to produce F2 progeny, and screened for recessive phenotypes. Once heritability
was established, mutant mice were assigned a number in the TVRM program [46] and lines
were bred and maintained in the JAX Research Animal Facility. Mutant strains were backcrossed five generations (N5) to the founder strain, B6.Cg-Crb1rd8/Pjn, to remove potential
unlinked mutations before samples for characterization were collected. The full designations
for the modifier strains are B6.Cg-Crb1rd8 Arhgef12Tvrm266/Pjn and B6.Cg-Crb1rd8
PrkciTvrm323/Pjn, which are abbreviated as Tvrm266 and Tvrm323, respectively, and refer to a
genotype that is homozygous for both Crb1rd8 and the modifier allele unless otherwise
indicated.
Mice were provided with NIH 6% fat chow diet and acidified water, with a 12:12 hour dark:
light cycle in pressurized individual ventilation caging and were monitored regularly to maintain a pathogen-free environment.

Fundus photodocumentation
Mouse pupils were dilated using 1% Cyclomydril (Alcon) prior to imaging. Isoflurane (Kent
Scientific) was delivered at 2–4% with an oxygen flow rate of 0.5 liter/min to anesthetize mice
during imaging. Color fundus videos (100 frames) were acquired using a Micron IV Retinal
Imaging Microscope (Phoenix Technology Group), and registered, averaged, and sharpened
in Fiji [111] using the ImageStabilizeMicronStack macro as described [112]. Images were further processed using a custom Fiji macro that applies the Polynomial Shading Corrector plugin
(degree x = 2, degree y = 2, regularization = 50) to flatten brightness across the image and
resets the range of each channel to optimize color balance.

Gene identification
Based on observations during initial breeding, the mutations in Tvrm266 and Tvrm323
appeared to segregate as semidominant alleles. To determine the map position of Tvrm323,
affected mice (enhanced spots) were outcrossed to C57BL/6NJ (B6N, JAX stock number
005304) and the resulting F1 progeny were backcrossed to B6N. All backcross progeny homozygous for the Crb1rd8 mutation were phenotyped by indirect ophthalmoscopy. DNA from
103 backcross progeny (59 unaffected, 44 enhanced) were genotyped with 149 single nucleotide polymorphisms (B6/B6N SNP panel) spanning the genome (JAX Fine Mapping Facility).
We identified genomic regions where >70% of the B6 allele co-segregated with the enhanced
phenotype. Candidate genes for Tvrm323 were identified in the minimal confidence interval
on Chr 3. Gene-specific PCR amplification and subsequent Sanger sequencing confirmed a
missense mutation in Prkci. To identify the causative mutation in Tvrm266, high-throughput
exome sequencing was performed on a whole-exome library created from Tvrm266 genomic
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DNA on a HiSeq 2000 Sequencing System (Illumina) as previously described [113]. Wholeexome sequencing of Tvrm266 identified a nonsense mutation in Arhgef12, which was subsequently confirmed by Sanger sequencing. An abbreviated mapping cross, with 16 progeny (8
unaffected, 8 enhanced) confirmed the cosegregation of the affected Tvrm266 phenotype with
the Arhgef12 mutation on Chr 9.
For strain maintenance, modifier mice were genotyped using DNA isolated from tail tips
incubated with 50 mM sodium hydroxide at 95˚C for about 20 min before being neutralized
with 1M Tris-Cl, pH 8.0, to a final concentration of 50 mM. PCR amplification was performed
in a 10 μl reaction volume containing 1X PCR Buffer (New England Biolabs), 10 μM dNTP
and 0.05 U Taq DNA polymerase (New England Biolabs). An initial denaturation step at 97˚C
for 2 minutes was followed by 45 cycles of 10 seconds at 95˚C, 15 seconds at 55˚C, and 30 seconds at 72˚C with a final 3 minute extension at 72˚C. Prkci genotypes were determined using
an allele-specific protocol combining the following primers (Eurofins Genomics): Prkci-F,
TCCAGCAGTAAGTATGGGAAAC; Prkci-WT-R, GTGTGGCCATTTGCACAACA; and
Prkci-MUT-R2, GTTTGGCTTGAAAAACGTGGCCATTTGCACAGTT. Depending on
zygosity, this protocol yielded amplified products of 145 bp (WT), 159 bp (mutant), or both.
Arhgef12 genotypes were determined by direct sequencing. DNA samples were amplified with
primers (Arhgef12-266seqF, CACACACACGTCACTGTAAA; mArhgef12-266seqR,
GAGTGCCTCAATCCACATAAG). The PCR products were purified and sequenced using
the reverse primer.

Western analysis
B6, B6 rd8, Tvrm266, and Tvrm323 mice (n = 4) adult eyes at approximately two months of
age were dissected in ice-cold PBS with EDTA-free protease inhibitor cocktail (Roche) to
remove the anterior eye and lens, and snap-frozen in eppendorf tubes on dry ice. Eyecups
were combined with 100 μl 1× NuPAGE LDS sample buffer/reducing agent (Invitrogen),
homogenized immediately using a hand-held pellet pestle motor (Kontes) on ice, and briefly
sonicated (Qsonica). Lysates were then centrifuged briefly at 16,000g. A dilution series of the
B6 samples was used to standardize the western signal. For eyecups at one month of age (S3
Fig) were combined with ice-cold RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate) containing EDTA-free protease inhibitor cocktail, homogenized, and
centrifuged for 20 min at 16,000g. The supernatant was collected and protein concentration
determined by Protein Assay reagent (Bio-Rad) using a DU530 spectrophotometer (Beckman
Coulter). For each sample, 20 μg was analyzed by gel electrophoresis. Samples were denatured
at 100˚C for 10 min and electrophoresed on a 10% Mini-Protean TGX gel (Bio-Rad). Electrophoresed proteins were transferred onto a nitrocellulose membrane using Turbo-blot Transfer
system (Bio-Rad). Membranes were pre-blocked in Blotto A (5% w/v milk powder in Trisbuffered saline, 0.05% Tween [TBS-T]), and incubated with antibodies against ARHGEF12
(Santa Cruz, sc-15439), PRKCI (Novus, NBP1-84959), or GAPDH (Cell Signaling, #2118) at
4˚C overnight. Membranes were washed in TBS-T and incubated with HRP-conjugated antigoat IgG (R&D, HAF017) or anti-rabbit IgG (Cell Signaling, 7074S) antibody in Blotto A
(1:1000) for 2 h at room temperature. Following washes in TBS-T, immunoblots were visualized using the Clarity ECLWestern Blot Detection System (Bio-Rad). Protein band images in
16-bit tif format were captured using an Azure c600 bioimaging system (Azure Biosystems).
The raw integrated densities of the ARHGEF12 or PRKCI bands, and the densities for
GAPDH bands on the same blots, were determined using Fiji following subtraction of a constant background value evaluated between lanes. The density values for the standard series
were plotted against load volume and fit to a hyperbolic curve in Prism, which was used to
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calculate the relative load volumes for all samples. Relative expression was determined by
dividing the equivalent load volumes of the ARHGEF12 or PRKCI bands by those of the corresponding GAPDH bands. The resulting values were normalized by dividing by the mean
ARHGEF12 or PRKCI values from all B6 samples.

RNA extraction and analysis
Total RNA was extracted from B6, B6 rd8, Tvrm266, and Tvrm323 mice (n = 5) at one month
of age by homogenizing posterior eyecups in TRIzol (Thermo Fisher) using a gentleMACS dissociator (Milteny Biotec). Chloroform was then added and the resulting aqueous phase transferred to 100% ethanol. RNA clean-up was performed using an RNeasy spin column kit
(Qiagen). DNase (Qiagen) treatment was performed according to the manufacturer’s instructions. Total RNA was eluted in RNase-free water, quantified using a NanoDrop ND1000 spectrophotometer (Thermo Fisher) and examined for quality using the TapeStation 4150 system
(Agilent Technologies). cDNA was synthesized using the Superscript IV Firststrand Synthesis
kit (Thermo Fisher).
To design primers for use in real time quantitative PCR, gene and coding sequences were
downloaded from mouse Ensembl (https://useast.ensembl.org). Forward and reverse primers
amplifying cDNA sequences of 150–250 bp and separated by large intronic regions in the
genomic sequence were designed using Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/),
which yielded Arhgef12 rt-F3 (AGAGCCATCAGTCACTGGACA) and Arhgef12 rt-R3
(CAGCCGTTCCTGTTCCTTC) for Arhgef12, and Prkci rt-F1 (GGAGTGAGGAGATGCC
GAC) and Prkci rt-R1 (TCATAATATCCCCGCGGTAG) for Prkci. For quantitative RT-PCR,
amplification using these primers was performed with iTaq Universal SYBR Supermix (BioRad Laboratories) using the CFX96 Real-time PCR Detection System (Bio-Rad). The relative
fold change of gene transcripts was calculated using the comparative CT method (ΔΔCT), and
2-ΔΔCT values were normalized to levels of Actb, an internal control calibrator. Melting curve
analysis was evaluated to confirm accurate amplification of the target genes.

Histological analysis
Following carbon dioxide euthanasia, eyes were enucleated, placed in chilled methanol:acetic
acid:phosphate-buffered saline (PBS) (3:1:4), fixed overnight at 4˚C, and stored in 70% ethanol. Fixed eyes were embedded in paraffin and 5 μm sections were stained with hematoxylin
and eosin or left unstained for immunohistochemistry (see below). Eyes were oriented to yield
sections parallel to the superior-inferior axis by marking the superior eye with a non-soluble
paint prior to enucleation. Eyes were also oriented using the long posterior ciliary arteries,
which serve as landmarks [114] and could be viewed from the back of embedded eyes illuminated through the cornea. Histosections were scanned using a NanoZoomer 2.0-HT digital
slide scanner (Hamamatsu) at 40× magnification; typically 18–21 sections were captured per
slide. Sections on the slide were reviewed using NDP.view 2 software (Hamamatsu) to ensure
correct orientation based on the position of the central retinal artery to one side of Bruch’s
membrane opening at the optic nerve head. All sections were reviewed for the presence of
pathological features, including dysplastic lesions, voids, or neovessels, and mice were graded
as affected if the feature was observed in one or more sections. To address whether voids were
an artifact of histological fixation, we reviewed NanoZoomer images from B6 eyes collected at
0.9–1.1 months of age over a period of nine years and found that no voids were present. To
assess photoreceptor cell loss from scanned images, a custom Fiji macro was first used to
extract .tif images of single sections from full-resolution NanoZoomer output files. A separate
macro was created to draw tilted rectangular regions of interest (ROIs) encompassing a 50 μm
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length of retina and spaced at 0.3 mm intervals starting from the optic nerve head. Photoreceptor cell loss was determined from .tif images by manually counting photoreceptor cell nuclei
within each ROI.

Immunohistochemistry
Unstained sections of eyes were deparaffinized through a xylene/alcohol gradient series. Following deparaffinization, antigen retrieval was performed by microwave treatment for 6 min
in 10 mM sodium citrate. Samples were treated with blocking solution (1:50 normal donkey
serum:PBS, 0.3% v/v Triton X-100) for 30 min at room temperature and then incubated overnight at 4˚C with primary antibodies against rhodopsin (MS-1233-R7, Thermo Fisher), green
opsin (AB5405, EMD Millipore), glutamine synthetase (ab176562, Abcam), phosphohistone
H3 (PHH3; ab14955, Abcam), P2YR12, (AS-55043A, AnaSpec), and TJP1 (339100 and 61–
7300, Thermo Fisher), all diluted 1:100 in blocking solution. Slides were washed using 1× PBS
prior to application of secondary antibodies at 1:200 in blocking solution for two h at room
temperature. Nuclei were stained using DAPI (10 μg/ml in PBS) for 5 min. Negative controls,
in which primary antibodies were omitted during the incubation stage, were performed in parallel. All samples were mounted in Vectashield (Vector Laboratories), coverslipped and imaged
using a Zeiss Axio Observer.z1 fluorescence microscope (Carl Zeiss Microscopy) with an ApoTome2 attachment. To count ELM gaps, ApoTome2 stacks encompassing the full thickness of
the stained section and covering the entire retina were acquired and processed to yield a maximum intensity projection using Zen 2.6 software (Carl Zeiss). The resulting images were
viewed in Fiji and gaps counted manually. The ELM was manually fit to a spline curve, avoiding dysplastic regions identified in the DAPI channel. The gap count was divided by the total
ELM length calculated from the fitted curves. To assess the distribution of mitotic nuclei at P0,
images were acquired with a 10× objective using the Zeiss microscope and ApoTome, and analyzed in Fiji to compare the intensity of PHH3 fluorescence at the apical NBL to that in the full
NBL as described previously [115].

ERG analysis
ERG analysis was carried out using a Espion V6 ColorDome Multifocal system (Diagnosys)
essentially as described [116]. Mice at four, eight, and 12 months of age were dark-adapted
overnight and pupils were dilated using 1% atropine sulfate (Akorn) or 1% cyclopentolate
(Akorn). Mice were anesthetized using ketamine (Covetrus) and xylazine (Akorn) diluted in
normal saline and administered by intraperitoneal injection at a final dose of 80 and 16 mg/kg
of body weight, respectively. Anesthetized mice were placed on the heated platform of the
Espion system. Gold loop electrodes were placed on the corneal surface of each eye along with
Goniovisc hypromellose ophthalmic solution (HUB Pharmaceuticals), Gonak (Akorn), or
Refresh (Allergan). Small needle electrodes beneath the skin at the top of the head and at the
tail served as reference and system ground, respectively. Eyes of dark-adapted mice were presented with a six-step protocol of increasing light intensity measuring mainly rod-dependent
responses, followed by light adaptation and a three-step protocol measuring cone-dependent
responses. The flash luminance (cd s m-2), number of sweeps, and time between sweeps (s) for
the dark-adapted series was 0.0025, 5, 5; 0.006, 5, 5; 0.016, 5, 5; 0.04, 5, 10; 0.1, 5, 15; and 0.25,
5, 15, respectively. Following a 10-min light adaptation at 110 cd/m2, the corresponding
parameters for the light-adapted series were 0.63, 10, 1; 4, 10, 1; and 10, 20, 1 on a background
illumination of 110 cd m-2. Response amplitudes were determined from the average of multiple sweeps as follows: scotopic a-wave, pre-flash baseline to the negative trough; scotopic
b-wave, negative trough to positive peak within 40–120 ms following the flash; photopic
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b-wave, negative trough to positive peak within 40–60 ms following the flash. The mean
response amplitude from both eyes of each mouse was used for statistical analysis; if data were
missing from one eye, only one eye was used.

Statistical analysis
Genotype-phenotype associations to identify the causative mutation and to determine the
association of strain with pathological features were assessed with Fisher’s Exact test using
JMP, Version 15 or 16 (SAS Institute). Quantitative immunoblotting and qRT-PCR data were
analyzed by one-way ANOVA and Student’s t-test, respectively, using Prism (GraphPad).
Genotype-phenotype association in epistasis crosses were analyzed by linear regression modeling. Heterozygous and homozygous genotypes were independently coded to assess allelic
dominance in both main and interaction effects. Significance was estimated by the ratio of Fstatistics between interactive and additive models, with p-values derived from the Fisher-Snedecor distribution. ERG results were analyzed in Prism using a mixed effect model to accommodate missing data and to allow the use of repeated measures; further analysis of normalized
data at the highest ERG flash intensities was performed in Prism using two-way ANOVA. A
significance threshold of p < 0.05 was used for all experiments.

Supporting information
S1 Fig. Genome-wide recombination mapping of the Tvrm323 mutation from 103 backcross progeny ((Tvrm323 × B6N) F1 × B6N). Each column indicates a SNP and is ordered
based on chromosome position. Homozygosity of the B6N allele is shown in yellow. The critical interval of the disease gene lies in the region highlighted in red, where �70% of the affected
progeny were heterozygous for the corresponding SNP.
(TIF)
S2 Fig. Identification of causative mutations. A. Candidate-gene sequencing of the Arhgef12
gene in B6 and affected Tvrm266 mice identified a mutation in both heterozygous and homozygous individuals (yellow highlight). The mutation corresponds to c.71T>A. B. Candidategene sequencing of the Prkci gene in B6 and affected Tvrm323 mice identified a mutation in
both heterozygous and homozygous individuals (yellow highlight). The sequencing chromatograms shown correspond to the antisense strand. The mutation corresponds to c.406T>A. C.
Co-segregation analysis of the disease phenotype with the Arhgef12 mutation in a small mapping cross of Tvrm266 mice with B6N mice. D. Co-segregation analysis of the disease phenotype with the Prkci mutation in the Tvrm323 mapping cross.
(TIF)
S3 Fig. Western analysis of ARHGEF12 in posterior eyecup lysates. Equal amounts (20 μg)
of B6, B6 rd8, and Tvrm266 lysates prepared at one month of age were electrophoresed, transferred to nitrocellulose membranes and probed with antibodies against ARHGEF12 and GAPDH.
Ponceau S staining was also performed to demonstrate equivalent loading of total protein.
(TIF)
S4 Fig. Quantitative western analysis of B6 and Tvrm266 or Tvrm323 eyecups collected
from mice at approximately two months of age. Eyecups were lysed in electrophoresis sample buffer. The volumes loaded for electrophoresis are indicated by the values (in μl) above the
blot images. The molecular weights of protein standards are indicated. A–E. ARHGEF12
quantitation. A. ARHGEF12 western blot. B. GAPDH western blot. C. Integrated intensities
from lanes shown in panel A. Intensity was measured within a subregion of each lane corresponding to the migration of ARHGEF12 and plotted against sample load volume. Intensities
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for the B6 standard curve are shown as black squares; the intensities for all 10 μl samples positioned along a hyperbolic fit to the standard curve are shown as red circles. D. Plot of integrated intensity and GAPDH bands from panel B. E. Relative ARHGEF12 levels and statistical
analysis. Bars show mean ± SD. F–J. PRKCI quantitation. The blot images and corresponding
analyses are identical to those in A–E, except antibody against PRKCI was used in panel F.
(TIF)
S5 Fig. Test of ELM fragmentation dependence on the homozygous Crb1rd8 allele. Ocular
sections from mice at 10–16 weeks of age (n = 4 for both strains) were stained with DAPI to
detect nuclei (blue) and TJP1 to detect the ELM (red). A. Tvrm266 mice at 10 weeks of age.
Gaps are indicated with yellow arrows. B. Mice bearing a homozygous Arhgef12Tvrm266 allele
and a heterozygous Crb1rd8 allele were obtained from epistasis matings, 10 weeks of age. No
gaps were observed. C. Quantitation of gaps per mm of ELM. Bars indicate mean ± SEM.
(TIF)
S1 Data. Data and statistical analysis to support the text, figures, and supporting information. Worksheet tabs correspond to individual data elements. Each worksheet includes the values used for plotting individual points and for computing cohort means and standard
deviation or standard error of the mean. The corresponding statistical analysis is also included
in each worksheet.
(XLSX)
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